A Phase 1 study of ABBV-701 in healthy adults
Active, Not Recruiting Phase 1 NCT06895343
Study Description
A study to evaluate the safety and pharmacokinetics of an investigational drug called ABBV-701 in healthy adults
Study Details
- Registry ID:
- NCT06895343
- Conditions:
- Healthy Volunteer
- Phase:
- Phase 1
- Target Enrollment:
- 100 participants
- Start Date:
- Age Range:
- 18–60 years
- Healthy Volunteers:
- No
Study Locations (2 sites)
-
Acpru /Id# 273354
Grayslake, Illinois, United States -
CenExel ACT- Anaheim Clinical Trials /ID# 278431
Anaheim, California, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.